secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0001193125-21-326070
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva issues €2.6B and $2B sustainability-linked notes; upsizes tender offer to $4B
--------------------------------------------------------------------------------

- €1.1B 3.750% notes due 2027 and €1.5B 4.375% notes due 2030 issued.
- $1B 4.750% notes due 2027 and $1B 5.125% notes due 2029 issued.
- Net proceeds used to fund tender offer for up to $4B (upsized from $3.5B) plus fees, debt repayment, and general purposes.
- Interest rates may increase by up to 0.375% from May 2026 if sustainability targets not met.
- Notes are senior unsecured obligations guaranteed by Teva; semi-annual interest begins May 9, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312521326070/0001193125-21-326070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312521326070/d249996d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-326070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer